| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
LFCR
Lifecore Biomedical
|
Sep 29, 2026 | HOLD |
Buy
+45.6% avg upside
10 analysts
|
$6.28
4.72% Downside
|
+0.0% | · |
|
RGEN
Repligen
|
Sep 25, 2026 | BUY |
Strong Buy
-11.6% avg upside
25 analysts
|
— | +0.0% | · |
|
PARK
Park Dental Partners, Inc.
|
Sep 24, 2026 | BUY |
Strong Buy
+5.0% avg upside
2 analysts
|
— | +1.5% | · |
|
LGND
Ligand Pharma
|
Sep 24, 2026 | BUY |
Strong Buy
-10.9% avg upside
16 analysts
|
— | +0.8% | · |
|
INFU
InfuSystem Holdings
|
Sep 24, 2026 | BUY |
Strong Buy
+23.7% avg upside
7 analysts
|
— | +0.0% | · |
|
CDXS
Codexis
|
Sep 22, 2026 | BUY |
Strong Buy
+646.0% avg upside
13 analysts
|
— | -5.0% | · |
|
TKNO
Alpha Teknova
|
Sep 17, 2026 | BUY |
Strong Buy
+32.4% avg upside
8 analysts
|
— | +25.2% | · |
|
OABI
OmniAb
|
Sep 15, 2026 | BUY |
Strong Buy
+69.2% avg upside
10 analysts
|
— | +9.0% | · |
|
MRVI
Maravai Lifesciences Holdings
|
Sep 15, 2026 | BUY |
Strong Buy
+98.9% avg upside
17 analysts
|
— | +10.9% | · |
|
OMCL
Omnicell
|
Sep 02, 2026 | BUY |
Strong Buy
+47.0% avg upside
12 analysts
|
— | -3.0% | · |
|
DYAI
Dyadic International
|
Aug 13, 2026 | BUY |
Strong Buy
+758.4% avg upside
3 analysts
|
$4.00
758.44% Upside
|
-45.5% | · |
|
CYRX
CryoPort
|
Aug 07, 2026 | BUY |
Strong Buy
-5.8% avg upside
15 analysts
|
$20.00
15.47% Upside
|
+14.9% | · |
|
CERT
Certara
|
Aug 04, 2026 | HOLD |
Buy
+41.8% avg upside
22 analysts
|
— | +10.8% | · |
|
BLFS
BioLife Solutions
|
Jul 22, 2026 | HOLD |
Buy
-24.7% avg upside
17 analysts
|
$31.00
20.94% Downside
|
+23.6% | · |
|
BHST
BioHarvest Sciences
|
Jul 15, 2026 | BUY |
Strong Buy
+513.8% avg upside
5 analysts
|
— | -48.8% | · |
|
SLP
Simulations Plus
|
Jul 08, 2026 | HOLD |
Buy
+105.1% avg upside
11 analysts
|
— | +1.1% | · |
|
SDGR
Schrodinger
|
Jul 08, 2026 | BUY |
Strong Buy
-11.4% avg upside
16 analysts
|
— | +79.3% | · |
|
MXCT
MaxCyte
|
Jul 02, 2026 | BUY |
Strong Buy
+238.9% avg upside
5 analysts
|
— | -4.5% | · |
|
RZLT
Rezolute
|
Jun 02, 2026 | HOLD |
Strong Buy
+175.9% avg upside
13 analysts
|
— | -2.5% | · |
|
APYX
Apyx Medical
|
May 08, 2026 | BUY |
Strong Buy
+852.9% avg upside
12 analysts
|
$6.00
130.79% Upside
|
-19.6% | · |
|
HSTM
HealthStream
|
May 06, 2026 | BUY |
Buy
+6.2% avg upside
8 analysts
|
$40.00
34.52% Upside
|
+26.1% | · |
|
BZAI
Blaize Holdings
|
Mar 25, 2026 | BUY |
Strong Buy
+552.4% avg upside
6 analysts
|
— | -60.0% | · |
|
CSBR
Champions Oncology
|
Dec 16, 2025 | BUY |
Strong Buy
+77.4% avg upside
6 analysts
|
$12.00
150.58% Upside
|
-26.8% | · |
|
VUZI
Vuzix
|
Dec 09, 2025 | BUY |
Strong Buy
+147.9% avg upside
8 analysts
|
— | -2.3% | · |
|
CLOV
Clover Health Investments
|
Oct 10, 2025 | BUY |
Hold
-8.8% avg upside
10 analysts
|
— | +69.0% | · |
|
FSLY
Fastly
|
Jun 17, 2025 | HOLD |
Buy
+31.1% avg upside
26 analysts
|
— | +162.6% | · |
|
NEO
NeoGenomics
|
Apr 25, 2025 | BUY |
Buy
-5.0% avg upside
18 analysts
|
— | -19.3% | · |
|
BWMN
Bowman Consulting Group
|
Mar 18, 2025 | BUY |
Buy
+1.6% avg upside
11 analysts
|
— | +12.5% | · |
|
EHTH
Ehealth
|
Dec 18, 2024 | BUY |
Buy
+2082.8% avg upside
19 analysts
|
— | -37.2% | · |
|
ISPC
iSpecimen
|
Aug 07, 2024 | BUY |
Strong Buy
+237.3% avg upside
3 analysts
|
— | · | · |
|
SRTS
Sensus Healthcare
|
Feb 09, 2024 | BUY |
Buy
+116.4% avg upside
8 analysts
|
$6.00
95.47% Upside
|
+50.4% | · |
|
TSE:ELVA
Electrovaya
|
Sep 21, 2023 | BUY |
Strong Buy
+101.7% avg upside
11 analysts
|
— | -20.1% | · |
|
TDOC
Teladoc
|
Feb 23, 2023 | HOLD |
Buy
+400.4% avg upside
38 analysts
|
— | -47.1% | · |
|
ANGO
AngioDynamics
|
Oct 04, 2019 | HOLD |
Strong Buy
+14.0% avg upside
9 analysts
|
$17.00
8.96% Upside
|
-21.2% | · |
|
VIVE
Viveve Medical
|
Jan 18, 2019 | HOLD |
Hold
+79999900.0% avg upside
8 analysts
|
$100.00
49999899.91% Upside
|
· | · |
|
TECH
Bio-Techne
|
Oct 31, 2018 | HOLD |
Buy
+15.2% avg upside
21 analysts
|
$154.00
112.69% Upside
|
+25.0% | · |
|
MDXG
MiMedx Group
|
Feb 27, 2018 | BUY |
Strong Buy
+125.8% avg upside
17 analysts
|
$19.00
306.90% Upside
|
-59.4% | · |
|
HAE
Haemonetics
|
Nov 08, 2017 | HOLD |
Buy
-19.5% avg upside
18 analysts
|
$50.00
52.79% Downside
|
+112.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.